CDO Antibodies

Santa Cruz Biotechnology features a diverse variety of CDO Antibodies for advanced research in cellular and molecular biology. CDO Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDO, or Cysteine Dioxygenase, plays a crucial role in regulating cysteine metabolism and synthesizing important biomolecules. CDO function is essential for maintaining cellular redox balance and influences various signaling pathways, making it a significant target for understanding numerous physiological and pathological processes. Researchers investigating CDO can uncover its role in cellular metabolism, oxidative stress responses, and potential therapeutic applications. Advanced detection methods using specific conjugates such as horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) enable precise visualization and quantification of CDO in experimental settings. Understanding CDO's involvement in health and disease can lead to breakthrough discoveries in metabolic disorders and therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for CDO research support scientists worldwide in advancing our understanding of cellular processes and disease mechanisms.